IRIDEX VP Ronald Steckel Sells 1,650 Shares (IRIX)
IRIDEX (NASDAQ:IRIX) VP Ronald Steckel unloaded 1,650 shares of the company’s stock on the open market in a transaction that occurred on Monday, May 19th. The stock was sold at an average price of $8.82, for a total value of $14,553.00. Following the completion of the sale, the vice president now directly owns 1,964 shares in the company, valued at approximately $17,322. The sale was disclosed in a document filed with the SEC, which is available at this link.
Shares of IRIDEX (NASDAQ:IRIX) traded up 1.62% on Tuesday, hitting $8.78. 28,029 shares of the company’s stock traded hands. IRIDEX has a 52-week low of $5.10 and a 52-week high of $11.00. The stock’s 50-day moving average is $8.74 and its 200-day moving average is $9.04. The company has a market cap of $87.4 million and a price-to-earnings ratio of 47.47.
IRIDEX (NASDAQ:IRIX) last issued its quarterly earnings data on Thursday, May 1st. The company reported $0.05 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.06 by $0.01. The company had revenue of $10.30 million for the quarter, compared to the consensus estimate of $8.90 million. On average, analysts predict that IRIDEX will post $0.20 earnings per share for the current fiscal year.
IRIDEX Corporation is a worldwide provider of therapeutic based laser systems, delivery devices and consumable instrumentation used to treat eye diseases in ophthalmology.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.